Your browser doesn't support javascript.
loading
Nanocages engineered from Bacillus Calmette-Guerin facilitate protective Vγ2Vδ2 T cell immunity against Mycobacterium tuberculosis infection.
Pi, Jiang; Zhang, Zhiyi; Yang, Enzhuo; Chen, Lingming; Zeng, Lingchan; Chen, Yiwei; Wang, Richard; Huang, Dan; Fan, Shuhao; Lin, Wensen; Shen, Hongbo; Xu, Jun-Fa; Zeng, Gucheng; Shen, Ling.
Afiliación
  • Pi J; Department of Clinical Immunology, Institute of Laboratory Medicine, School of Medical Technology, The First Dongguan Affiliated Hospital, Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Guangdong Medical University, Dongguan, 523808, China. jiangpi@gdmu.edu.cn.
  • Zhang Z; Department of Microbiology and Immunology, University of Illinois at Chicago, Chicago, IL, 60612, USA. jiangpi@gdmu.edu.cn.
  • Yang E; Department of Microbiology, Zhongshan School of Medicine, Key Laboratory for Tropical Diseases Control of the Ministry of Education, Sun Yat-Sen University, Guangzhou, 510080, Guangdong, China.
  • Chen L; Department of Microbiology and Immunology, University of Illinois at Chicago, Chicago, IL, 60612, USA.
  • Zeng L; Clinic and Research Center of Tuberculosis, Shanghai Key Lab of Tuberculosis, Shanghai Pulmonary Hospital, Institute for Advanced Study, Tongji University School of Medicine, Shanghai, China.
  • Chen Y; Department of Microbiology, Zhongshan School of Medicine, Key Laboratory for Tropical Diseases Control of the Ministry of Education, Sun Yat-Sen University, Guangzhou, 510080, Guangdong, China.
  • Wang R; Clinical Research Center, Department of Medical Records Management, Guanghua School of Stomatology, Hospital of Stomatology, Sun Yat-Sen University, Guangzhou, 510080, Guangdong, China.
  • Huang D; Department of Microbiology, Zhongshan School of Medicine, Key Laboratory for Tropical Diseases Control of the Ministry of Education, Sun Yat-Sen University, Guangzhou, 510080, Guangdong, China.
  • Fan S; Department of Microbiology and Immunology, University of Illinois at Chicago, Chicago, IL, 60612, USA.
  • Lin W; Department of Microbiology and Immunology, University of Illinois at Chicago, Chicago, IL, 60612, USA.
  • Shen H; Department of Clinical Immunology, Institute of Laboratory Medicine, School of Medical Technology, The First Dongguan Affiliated Hospital, Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Guangdong Medical University, Dongguan, 523808, China.
  • Xu JF; Department of Clinical Immunology, Institute of Laboratory Medicine, School of Medical Technology, The First Dongguan Affiliated Hospital, Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Guangdong Medical University, Dongguan, 523808, China.
  • Zeng G; Clinic and Research Center of Tuberculosis, Shanghai Key Lab of Tuberculosis, Shanghai Pulmonary Hospital, Institute for Advanced Study, Tongji University School of Medicine, Shanghai, China.
  • Shen L; Department of Clinical Immunology, Institute of Laboratory Medicine, School of Medical Technology, The First Dongguan Affiliated Hospital, Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Guangdong Medical University, Dongguan, 523808, China. xujunfa@gdmu.edu.cn.
J Nanobiotechnology ; 20(1): 36, 2022 Jan 15.
Article en En | MEDLINE | ID: mdl-35033108
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 / 3_ND Problema de salud: 2_enfermedades_transmissibles / 3_zoonosis Asunto principal: Tuberculosis / Vacuna BCG / Linfocitos T CD8-positivos / Nanoestructuras / Mycobacterium tuberculosis Límite: Animals Idioma: En Revista: J Nanobiotechnology Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 / 3_ND Problema de salud: 2_enfermedades_transmissibles / 3_zoonosis Asunto principal: Tuberculosis / Vacuna BCG / Linfocitos T CD8-positivos / Nanoestructuras / Mycobacterium tuberculosis Límite: Animals Idioma: En Revista: J Nanobiotechnology Año: 2022 Tipo del documento: Article País de afiliación: China